Deutsch Peter E. 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-11-14 3:13 pm Purchase |
2023-09-08 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Deutsch Peter E. | 383,659 9.480% |
383,659![]() (New Position) |
Filing |